tiprankstipranks
Entheon Biomedical (ENTBD)
OTHER OTC:ENTBD

Entheon Biomedical (ENTBD) Technical Analysis

33 Followers

Technical Sentiment

Overall Consensus
Sell
3Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
9Bearish
Entheon Biomedical’s (ENTBD) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Entheon Biomedical is a Sell.
Entheon Biomedical’s (ENTBD) 20-Day exponential moving average is 0.10, while Entheon Biomedical’s (ENTBD) share price is $0.107, making it a Sell.
Entheon Biomedical’s (ENTBD) 50-Day exponential moving average is 0.12, while Entheon Biomedical’s (ENTBD) share price is $0.107, making it a Sell.

Entheon Biomedical (ENTBD) Pivot Points

May 16, 2024, 06:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.06
0.07
0.09
0.10
0.12
0.13
0.14
Fibonacci
0.07
0.08
0.09
0.10
0.11
0.12
0.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Entheon Biomedical (ENTBD) Moving Averages

May 16, 2024, 06:14 AM
Period
Simple
Exponential
MA5
0.12Sell
0.11Sell
MA10
0.10Sell
0.11Sell
MA20
0.09Buy
0.10Sell
MA50
0.12Sell
0.12Sell
MA100
0.16Sell
0.14Sell
Entheon Biomedical’s (ENTBD) 10-Day exponential moving average is 0.11, while Entheon Biomedical’s (ENTBD) share price is $0.107, making it a Sell.
Entheon Biomedical’s (ENTBD) 100-Day exponential moving average is 0.14, while Entheon Biomedical’s (ENTBD) share price is $0.107, making it a Sell.
Entheon Biomedical’s (ENTBD) stock price is $0.107 and Entheon Biomedical’s (ENTBD) 50-day simple moving average is 0.12, creating a Sell signal.
Entheon Biomedical’s (ENTBD) stock price is $0.107 and Entheon Biomedical’s (ENTBD) 100-day simple moving average is 0.16, creating a Sell signal.

Entheon Biomedical (ENTBD) Technical Indicators

May 16, 2024, 06:14 AM
Name
Value
Implied Action
RSI (14)
48.69
Neutral
STOCH (9,6)
43.78
Neutral
STOCHRSI (14)
36.31
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
20.63
Neutral
Williams %R
-69.11
Buy
CCI (14)
90.91
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
39.19
Neutral
ROC
-44.44
Sell
Entheon Biomedical’s (ENTBD) Relative Strength Index (RSI) is 48.69, creating a Neutral signal.
Entheon Biomedical’s (ENTBD) Trend Strength Indicator (ADX) is 20.63, creating a Neutral signal.
Entheon Biomedical’s (ENTBD) Commodity Channel Index (CCI) is 90.91, creating a Neutral signal.
Entheon Biomedical’s (ENTBD) Price Rate of Change (ROC) is -44.44, creating a Sell signal.

FAQ

Is ENTBD a Buy, Hold, or Sell?
Based on ENTBD’s technical indicators, ENTBD is a Sell.
    What is ENTBD’s RSI (14)?
    ENTBD’s RSI (14) is 48.69, which suggests ENTBD is a Neutral.
      What is ENTBD’s MACD?
      ENTBD’s MACD is >-0.01, which suggests ENTBD is a Sell.
        What is ENTBD’s 5-day moving average?
        ENTBD’s 5-day moving average is 0.12, which suggests ENTBD is a Sell.
          What is ENTBD’s 20-day moving average?
          ENTBD 20-day moving average is 0.09, which suggests ENTBD is a Buy.
            What is ENTBD’s 50-day moving average?
            ENTBD’s 50-day moving average is 0.12, which suggests ENTBD is a Sell.
              What is ENTBD’s 200-day moving average?
              Currently, no data Available
              What is ENTBD’s Williams % R (14)?
              ENTBD’s Williams % R (14) is -69.11, which suggests ENTBD is a Buy.
                What is ENTBD’s CCI (14)?
                ENTBD’s CCI (14) is 90.91, which suggests ENTBD is a Neutral.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis